Fred E Cooperrider
Examiner (ID: 11124)
Most Active Art Unit | 2723 |
Art Unit(s) | 2723, 2623 |
Total Applications | 39 |
Issued Applications | 33 |
Pending Applications | 2 |
Abandoned Applications | 4 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 4157974
[patent_doc_number] => 06107457
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-22
[patent_title] => 'Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth'
[patent_app_type] => 1
[patent_app_number] => 8/390353
[patent_app_country] => US
[patent_app_date] => 1995-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 28
[patent_no_of_words] => 26449
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/107/06107457.pdf
[firstpage_image] =>[orig_patent_app_number] => 390353
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/390353 | Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth | Feb 15, 1995 | Issued |
Array
(
[id] => 3780529
[patent_doc_number] => 05821053
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'LIL-Stat DNA binding sites and methods for identifying inhibitory binding agents'
[patent_app_type] => 1
[patent_app_number] => 8/386728
[patent_app_country] => US
[patent_app_date] => 1995-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8114
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821053.pdf
[firstpage_image] =>[orig_patent_app_number] => 386728
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/386728 | LIL-Stat DNA binding sites and methods for identifying inhibitory binding agents | Feb 9, 1995 | Issued |
Array
(
[id] => 3825408
[patent_doc_number] => 05731294
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-24
[patent_title] => 'Inhibition of neovasularization using VEGF-specific oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/378860
[patent_app_country] => US
[patent_app_date] => 1995-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 11169
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/731/05731294.pdf
[firstpage_image] =>[orig_patent_app_number] => 378860
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/378860 | Inhibition of neovasularization using VEGF-specific oligonucleotides | Jan 25, 1995 | Issued |
Array
(
[id] => 3989608
[patent_doc_number] => 05891684
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Base-modified enzymatic nucleic acid'
[patent_app_type] => 1
[patent_app_number] => 8/363254
[patent_app_country] => US
[patent_app_date] => 1994-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 11390
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891684.pdf
[firstpage_image] =>[orig_patent_app_number] => 363254
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/363254 | Base-modified enzymatic nucleic acid | Dec 22, 1994 | Issued |
Array
(
[id] => 4213175
[patent_doc_number] => 06087095
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'DNA sequencing method'
[patent_app_type] => 1
[patent_app_number] => 8/325224
[patent_app_country] => US
[patent_app_date] => 1994-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 17233
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087095.pdf
[firstpage_image] =>[orig_patent_app_number] => 325224
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/325224 | DNA sequencing method | Dec 8, 1994 | Issued |
Array
(
[id] => 3624474
[patent_doc_number] => 05620887
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => 'Transcriptional cofactor DCoH'
[patent_app_type] => 1
[patent_app_number] => 8/340136
[patent_app_country] => US
[patent_app_date] => 1994-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 13840
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/620/05620887.pdf
[firstpage_image] =>[orig_patent_app_number] => 340136
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/340136 | Transcriptional cofactor DCoH | Nov 14, 1994 | Issued |
Array
(
[id] => 3825092
[patent_doc_number] => 05759817
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Heterodimeric receptor libraries using phagemids'
[patent_app_type] => 1
[patent_app_number] => 8/322730
[patent_app_country] => US
[patent_app_date] => 1994-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 44251
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 398
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/759/05759817.pdf
[firstpage_image] =>[orig_patent_app_number] => 322730
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/322730 | Heterodimeric receptor libraries using phagemids | Oct 11, 1994 | Issued |
08/321427 | SELECTIVE INHIBITION OF INTERNALLY INITIATED RNA TRANSLATION | Oct 10, 1994 | Abandoned |
Array
(
[id] => 3757891
[patent_doc_number] => 05843703
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Enhanced production of toxic polypeptides in prokaryotes'
[patent_app_type] => 1
[patent_app_number] => 8/296087
[patent_app_country] => US
[patent_app_date] => 1994-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 6639
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843703.pdf
[firstpage_image] =>[orig_patent_app_number] => 296087
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/296087 | Enhanced production of toxic polypeptides in prokaryotes | Aug 24, 1994 | Issued |
Array
(
[id] => 4148967
[patent_doc_number] => 06103226
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Genetically engineered cells that produce produce L. Dopa'
[patent_app_type] => 1
[patent_app_number] => 8/290028
[patent_app_country] => US
[patent_app_date] => 1994-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 11022
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103226.pdf
[firstpage_image] =>[orig_patent_app_number] => 290028
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/290028 | Genetically engineered cells that produce produce L. Dopa | Aug 11, 1994 | Issued |
Array
(
[id] => 1388179
[patent_doc_number] => 06544755
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-08
[patent_title] => 'Method and reagent for treatment of diseases by expression of the c-Myc gene'
[patent_app_type] => B1
[patent_app_number] => 08/192943
[patent_app_country] => US
[patent_app_date] => 1994-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10012
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/544/06544755.pdf
[firstpage_image] =>[orig_patent_app_number] => 08192943
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/192943 | Method and reagent for treatment of diseases by expression of the c-Myc gene | Feb 6, 1994 | Issued |
Array
(
[id] => 492873
[patent_doc_number] => 07211380
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-05-01
[patent_title] => 'Physiologically active polypeptide and DNA'
[patent_app_type] => utility
[patent_app_number] => 08/192800
[patent_app_country] => US
[patent_app_date] => 1994-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 5657
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/211/07211380.pdf
[firstpage_image] =>[orig_patent_app_number] => 08192800
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/192800 | Physiologically active polypeptide and DNA | Feb 6, 1994 | Issued |
Array
(
[id] => 4105111
[patent_doc_number] => 06022686
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-08
[patent_title] => 'Assay method'
[patent_app_type] => 1
[patent_app_number] => 8/101105
[patent_app_country] => US
[patent_app_date] => 1993-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11659
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/022/06022686.pdf
[firstpage_image] =>[orig_patent_app_number] => 101105
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/101105 | Assay method | Aug 2, 1993 | Issued |
11/885476 | Oligoribonucleotides and Methods of Use Thereof for Treatment of Ocular Scarring and Other Fibrotic Conditions | - | Abandoned |